Clinical Trial Update: Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and efficacy study of Imexon in multiple myeloma has completed, reporting the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Imexon (imexon)

Snippet

Sponsor: AmpliMed Corporation | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED